AR and androgen insensitivity syndrome: Considering the finding that androgen receptor (Ar) is known to be associated with androgen insensitivity syndrome (AIS) and that a lot of mutations with unknown functions have been reported in human patients (Radmayr et al., 1997; Lek et al., 2018), we decide to target Ar using the two CBEs.